The coexistence of parkinsonism-like symptoms and tardive dyskinesia
- PMID: 6120656
- DOI: 10.1176/ajp.139.3.341
The coexistence of parkinsonism-like symptoms and tardive dyskinesia
Abstract
The authors used the Simpson-Angus Neurological Rating Scale and the Simpson Abbreviated Dyskinesia Rating Scale to evaluate 132 psychiatric inpatients for the presence of parkinsonism-like symptoms and tardive dyskinesia, respectively. Ninety-four percent of these patients had been on a stable drug regimen for a minimum of 2 weeks before assessment; 91% were being treated with neuroleptics, 42% with antiparkinson agents, and 7% with tricyclic antidepressants. Tardive dyskinesia and parkinsonism-like symptoms coexisted in 17.4% of the 132 patients. Such coexistence poses a therapeutic dilemma for the clinician because drug treatment of improve one neurological condition may exacerbate the other.
Similar articles
-
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.J Clin Psychiatry. 1984 Jan;45(1):28-30. J Clin Psychiatry. 1984. PMID: 6141157
-
Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.J Clin Psychiatry. 1988 Apr;49(4):139-41. J Clin Psychiatry. 1988. PMID: 2895762
-
The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.Schizophr Res. 1997 Aug 29;26(2-3):235-42. doi: 10.1016/s0920-9964(97)00058-3. Schizophr Res. 1997. PMID: 9323356
-
[Tardive dyskinesia induced by neuroleptics. A review of the literature].Encephale. 1979;5(4):317-37. Encephale. 1979. PMID: 42528 Review. French.
-
Changing epidemiology of tardive dyskinesia: an overview.Am J Psychiatry. 1981 Mar;138(3):297-309. doi: 10.1176/ajp.138.3.297. Am J Psychiatry. 1981. PMID: 6110344 Review.
Cited by
-
Tardive dyskinesia.West J Med. 1990 Nov;153(5):535-41. West J Med. 1990. PMID: 1979705 Free PMC article. Review.
-
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.Psychopharmacology (Berl). 1995 Mar;118(2):142-9. doi: 10.1007/BF02245832. Psychopharmacology (Berl). 1995. PMID: 7617800
-
Drug-induced movement disorders.Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
-
Neuroleptic-induced dysphagia: case report and literature review.Dysphagia. 2007 Jan;22(1):63-7. doi: 10.1007/s00455-006-9032-9. Epub 2006 Oct 6. Dysphagia. 2007. PMID: 17024549 Review.
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.Front Pharmacol. 2016 Sep 28;7:343. doi: 10.3389/fphar.2016.00343. eCollection 2016. Front Pharmacol. 2016. PMID: 27733830 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources